Moderna’s 177% Cancer Vaccine Shock

Welcome to LazyListen. This is The Daily Rip for today. Moderna’s cancer vaccine news sent shockwaves through the market Wednesday, sparking a massive rally in biotech and oncology stocks.

The company reported positive Phase 3 results for its personalized mRNA cancer vaccine, intismeran, used alongside Merck’s Keytruda in high-risk melanoma patients. While the full data and hazard ratios are still pending a medical meeting later this year, the headline was enough to nearly triple Moderna’s stock price in a single day. Shares surged 177 percent on volume more than 30 times the usual pace, while Merck hit a record high with a thirteen percent gain.

Other biotech names like BioNTech, Thermo Fisher, and Lilly also climbed between four and twenty-four percent, as the oncology sector lit up with momentum. This trial involved over a thousand patients and showed the vaccine combo delayed cancer recurrence and spread better than Keytruda alone. But analysts caution that the market’s enthusiasm may be premature, with some calling the idea of using this vaccine after every surgery an overreach.

Manufacturing personalized vaccines is complex, and the full data will be critical to justify these lofty valuations. Still, the excitement underscores the potential for mRNA technology to revolutionize cancer treatment, opening a new frontier in biotech innovation. Shifting gears to consumer staples, Estée Lauder delivered a strong quarter that capped a turnaround year for the beauty giant.

6 billion dollars, with adjusted earnings per share rising sixty six percent to thirty nine cents. Sales grew five percent overall, driven by skincare, fragrance, and strength in China, travel retail, and online channels. Estée Lauder’s shares jumped sixteen percent on heavy volume, reflecting renewed investor confidence.

Management raised its fiscal 2027 outlook, expecting three to five percent organic sales growth and projecting more than a billion dollars in annual savings from restructuring. This marks a solid recovery after three years of declining revenue, signaling that premium beauty brands can still thrive amid changing consumer habits. On the tech front, OpenAI and Anthropic are gearing up for IPOs likely before year-end, stirring buzz and skepticism on social media.

3 billion dollars. 6 billion dollars and posted a small adjusted profit, overtaking OpenAI in size for the first time. I.

models. Recently, OpenAI paused development of its next big model for two weeks citing security concerns, fueling chatter that the company is trying to manage spending ahead of its IPO. I.

technologies rather than immediate profitability. In other earnings news, Walmart reports Thursday morning, with investors watching for signs on retail resilience and supply chain progress. Deere and Ross Stores also report, offering insights into industrial demand and consumer spending trends as the economy navigates inflation and interest rate pressures.

Looking at quick movers, brokerage Webull posted a record quarter with revenue up fifty one percent and adjusted operating profit hitting 63 million dollars. Customer assets jumped nearly eighty percent, fueling a twenty percent stock gain. Despite the strong results, investors are debating how much of Robinhood’s valuation premium Webull deserves as competition heats up in retail trading platforms.

In semiconductor land, Wolfspeed beat loss expectations but still reported a hefty net loss of 145 million dollars on revenue decline to 150 million dollars. I. data-center business more than doubled revenue, but the outlook remains cautious with projected revenue between 140 and 160 million dollars next quarter.

The market is weighing growth potential against ongoing losses in this capital-intensive sector. Crypto miner BitMine surged twelve percent alongside Ethereum’s rally after revealing its treasury now holds nearly six million ETH, about five percent of the circulating supply. While this signals strong crypto exposure, concerns remain over dilution and the volatile nature of digital assets, keeping sentiment mixed.

m. Eastern, a critical gauge of labor market health. Earnings to watch pre-market include Walmart, Kandi Technologies, Canaan, and Deere, while Ross Stores, Flux Power, and FinVolution report after the close.

These reports will offer fresh clues on consumer demand, industrial activity, and emerging tech trends as investors digest a fast-moving market landscape. I. IPOs spotlighting tech’s high-stakes race.

Meanwhile, retail brokers, semiconductors, and crypto miners showed mixed signals, reflecting ongoing sector rotations and investor caution. Tomorrow’s data and earnings will be key to confirming whether these themes hold or shift as the market navigates inflation, innovation, and economic uncertainty. Thanks for listening.

Catch you next time on LazyListen.